Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con COVID-19 que presentan coagulopatía por sepsis (40% vs 64.2% [p=0.029]) o dímero D >6 veces ULN (32.8% vs 52.4% [p=0.017]). DOI: https://t.co/LhfvOpQ22x https://t.co/eAFDvFKdIY
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2020 – Mar 2025Where it's discussed
-
X / Twitter282 posts
-
News35 articles
-
Blogs12 articles
-
Facebook6 posts
-
YouTube3 videos
-
Reddit3 posts
-
Bluesky2 posts
AI synopsis
What people are saying
Numerous discussions highlight the correlation between anticoagulant use and reduced mortality rates, citing specific data points and studies, such as a mention of the effectiveness of low molecular weight heparin (LMWH) in patients with elevated D-dimer levels. Terms like 'groundbreaking' and 'game changer' are used, suggesting a tone of urgency and optimism about the implications of this research on clinical practices.
Overall, there is moderate support for the findings of the publication, with many users acknowledging the potential benefits of anticoagulants.
The discussions show high levels of curiosity, with many users eager to explore the implications of anticoagulant treatments for COVID-19 patients.
While users are engaged, many are primarily sharing information rather than delving deeply into the methodologies or implications.
There is a strong consensus that this research could significantly influence treatment protocols in severe COVID-19 cases.
Abstract in brief
- Anticoagulant treatment, particularly with low molecular weight heparin, may lower mortality rates in severe COVID-19 patients with coagulopathy.
- A study analyzed 449 severe COVID-19 patients, finding no significant overall difference in 28-day mortality between those who received heparin and those who did not.
- However, patients with higher SIC scores or significantly elevated D-dimer levels showed a notable decrease in mortality when treated with heparin.
Top posts
Most liked on X and BlueskyTang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYvSxWT Ref: https://t.co/myx7pxuzg9 #coronavirus #COVIDー19 #sarscov2 #foam #foamed #foamems #meded #foamcc #covid19primaria #mfyc #enarm #mir https://t.co/hxikyubylo
18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at anticoagulation, an area of intense interest given propensity of Covid patients to clot. Both studies showed better outcomes for some patients w/ severe Covid.
@iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmurthy @willsuh76 V interesting webinar from Int'l Soc of Haemostasis Thrombosis - Retrospective analysis of 449 severe #COVID19 pts from China shows 40% mortality in pts tx w heparin vs 64% tx without. (Tang, N. et al J Thrombosis & Haemostasis. https://t.co/ThU72ygX2q) @ethanjweiss @willsuh76
@orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy (China) https://t.co/JxKabFDaK2
All mentions
Impact of COVID-19 on Thrombosis Risk and Treatment Options
In this video, Dr. Juliana explains how coronavirus infection can increase thrombosis risk. She discusses scientific studies on the relationship between COVID-19 and thrombotic events, highlighting the importance of…
Managing L type COVID-19 patients: Coronavirus Pandemic—Daily Report with Rishi Desai, MD, MPH
COVID 19: MANEJO DE LA CLÍNICA TERAPIA ????
Anticoagulant Treatment and Mortality in Severe COVID-19 Patients
Anticoagulant treatment, particularly low molecular weight heparin, may reduce mortality in severe COVID-19 patients with coagulopathy. A study of 449 patients revealed significant benefits for those with higher SIC…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
@deepbluediver77 @derGregor1 @berlinerzeitung https://t.co/7GooJjvxiJ https://t.co/5UVH53aeXW https://t.co/xAghuaMsAR https://t.co/XQbPreO2mo https://t.co/WJeUQ1NYqA https://t.co/1eDWdlTUuB https://t.co/6hJXevd2Pg https://t.co/ukbCkO8Zu3 Das sind nur einige. Es gibt noch mehr. Dazu kommen Paper von 2021 mit Daten aus 2020.
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/uvNB01YcqE
https://t.co/NojaIMN2vq 抗血栓治療で…あーん? 感染者の死亡率が下がる? おー?
Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer. https://t.co/4UeOhKESDF
@Darth_Morkai @RozekTom Także teges: https://t.co/cJHZH6ESSJ 20% to już superlek, ale szczepionka 50% to już badziew? Dobrze rozumiem?
RT @JTHjournal: We are counting down the top JTH articles of 2020! The number 1 article in JTH from 2020: Anticoagulant treatment is associ…
RT @ociredeF_MD: Primeras evidencias de lo que se venia observando. Anticoagulant treatment is associated with decreased mortality in seve…
RT @JTHjournal: We are counting down the top JTH articles of 2020! The number 1 article in JTH from 2020: Anticoagulant treatment is associ…
RT @JTHjournal: We are counting down the top JTH articles of 2020! The number 1 article in JTH from 2020: Anticoagulant treatment is associ…
We are counting down the top JTH articles of 2020! The number 1 article in JTH from 2020: Anticoagulant treatment is associated with decreased mortality in severe #COVID-19 patients with coagulopathy. Read the most shared article from 2020 at https://t.co/jVahWCFKwm. https://t.co/0WRFsKz77x
@RafaelOsswald Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis : JTH. 2020
@jluigis @doctormacias Este estudio menciona antes la posible utilidad de las heparinas en estos pacientes. https://t.co/bdOxSfqReG
@rosa_alcalde @LRsecreta @Nestor_Baez @eldiarioes Mire, de marzo. Y despues de esta, hay mil noticias que le siguen desde entonces y cada vez con más datos. https://t.co/WT3XptLhXC
@SafaMote About 40% of the COVID deaths are cardiac related. Not sure if your friend's mother would be a candidate but Heparin when properly administered has been linked to deceased mortality rates. https://t.co/W7erF97yzl
RT @Pineda_shir: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopat…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy - Tang - 2020 - Journal of Thrombosis and Haemostasis - Wiley Online Library https://t.co/5oArqHJGnt
@BiologiScienza @pasqualemariob1 La banale domanda prof of whoknowswhat @pasqualemariob1 e' se si e' tenuto update con la letteratura scientifica? perche di dati/articoli su autopsie, coagulopatia, e anticoagulanti come trattamento (https://t.co/Sthegl30Hr) ce ne sono parecchi. La sua ipotesi sembra infondata.
@Pravduh15 @abledoc https://t.co/170OxYyWKy
@VPrasadMDMPH https://t.co/W7erF97yzl
@JulianFMartinez @HOLLMANMORRIS @petrogustavo heparin https://t.co/xBew8q2cpS https://t.co/YNg52Gte6I https://t.co/ehyBaB51HP https://t.co/rTDjvtwXhG
@yoncabulutmd @MGHMedicine This is an adult study: https://t.co/osehFffAN8 shows increasing risk of mortality with higher d-dimers and SIC scores. Argues for a tailored approach
@cnni @jaketapper This observation is ground breaking. Comorbids w HBP &/or CAD r most susceptible to COVID. Could a combination treatment of Heparin & Dexamethasone be an effective end stage COVID treatment? Any combination side effects? anticoagulant & a steroid https://t.co/AYp67SS2m1
@FZores @tolquen @nathanpsmad @Damkyan_Omega @Larhumato @Curiolog @GilbertDeray @TroncheBiais @OlivierHertel @Barbusceptique @axelkahn @ValeryRidde si RCT cible bien les COVID chez qui c'est nécessaire (D Dimmer et SIC), il y a eu quelques indications d'effets positifs sur mortalité. dinon ce sera comme avec tout le reste. mauvais ciblage. mauvais resultats. https://t.co/vrhBZ7wFY3
@ricardolugon Deveria importar porque isso faz diferença nos protocolos de tratamento. Aliás, vale ler este artigo: https://t.co/MlGRnZRhqH
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/qMSVn5o5h7
RT @mzkhalil: Anticoagulant therapy improves survival in severe #Covid_19 patients with elevated D-dimer levels. https://t.co/QL2FxI5yoV h…
@mtbastin @MegriMohammed @emily_fri @iwashyna @ogi_gajic Reasons to pre emptively treat? Not a lot of data. small study from China going by dDimer and SIC score https://t.co/JwUqdOjNlr Larger population, showing improved mortality in ventilated patients, though not separated based on indication for AC https://t.co/iPVSl2eACx
@Jim_Caron @drdavidsamadi just a quick fact: HQC is a mast cell stabilizer. Mast cells contain heparin, which is dumped when degranulation occurs (mast cause inflamtn). Covid can be affected by heparin pathway as can malaria. so of course HQC is effective at treating symptoms. FYI: https://t.co/Xsm09b66jt
@austinbarnard45 Not sure if it helps, but here's a few articles: Might be good to check blood coagulation levels.
Los pacientes con un D-dímero más alto y recuento de plaquetas más bajo tenían tasas de mortalidad más altas, probablemente relacionado a la CID asociada a sepsis, la cual se ha demostrado que se correlaciona con peor evolución. El estudio:
RT @JTHjournal: Great new #COVID19 visual abstract by @2minmed https://t.co/rXNnLOLpmV on link anti #coagulation
RT @JTHjournal: Great new #COVID19 visual abstract by @2minmed https://t.co/rXNnLOLpmV on link anti #coagulation
RT @JTHjournal: Great new #COVID19 visual abstract by @2minmed https://t.co/rXNnLOLpmV on link anti #coagulation
RT @JTHjournal: Great new #COVID19 visual abstract by @2minmed https://t.co/rXNnLOLpmV on link anti #coagulation
Great new #COVID19 visual abstract by @2minmed https://t.co/rXNnLOLpmV on link anti #coagulation
RT @Stago_Official: #Anticoagulant treatment is associated with decreased mortality in severe #coronavirus disease 2019 patients with #coag…
#Anticoagulant treatment is associated with decreased mortality in severe #coronavirus disease 2019 patients with #coagulopathy. Check it out here: https://t.co/zq5Z3vXTQG https://t.co/y9avvXjGPs
PubMed- https://t.co/ztgsFh2Ebc Reply to "Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy" @HUCA_Asturias #publiHUCA @rubencotoh #InternalMedicine
RT @AtomsksSanakan: PapersOfTheDay "Anticoagulant treatment is associated with decreased mortality in severe Coronavirus [...]" https://t.…
PapersOfTheDay "Anticoagulant treatment is associated with decreased mortality in severe Coronavirus [...]" https://t.co/Ipa8L0JTND "Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19" https://t.co/8Tio0BOxbn https://t.co/h1NQs5zba1
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy D-Dimer of 3 or higher value to treat! https://t.co/JB1VhYLBNy @AliRaja_MD @srrezaie @ACEPNow @ACCinTouch @ShariqShamimMD @harvardmed @EmoryUniversity https://t.co/hDjLbpdbOr
Ma i cinesi sono stati i primi mostrare con uno studio serio che parte (parte!) dei pazienti sviluppa CID e può beneficiare di terapia anticoagulante (ma solo quelli, gli altri potrebbero averne danno!): https://t.co/cmQz8kJdtN Da notare: pazienti GRAVI non ai primi sintomi.
@METALBLADE28 2/2 https://t.co/Qzf3PqGpYT https://t.co/eEGGbECprv https://t.co/5kYjsfjccu https://t.co/EpQm74BjJD https://t.co/cnv4ArrrcB https://t.co/tE6wrVwTly https://t.co/HmyLbQ3A1m Farid Jalali, MD - https://t.co/TZqTbe0sXj (@farid__jalali Twitter) https://t.co/0Js4CW18L4
@METALBLADE28 Yes: * - Prophylaxis LWMH, Heparin or other blood thinners, &/or platelet blockers to prevent confirmed microvascular thrombosis/DIC/hypercoaguable states. Monitoring D-dimer. https://t.co/BcM46P8UtO https://t.co/hrrdBmqzin https://t.co/FHlfDreQME https://t.co/nyx16QLypz 1/2
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy D-Dimer of 3 or higher value to treat! https://t.co/JB1VhYLBNy @AliRaja_MD @srrezaie @ACEPNow @ACCinTouch @ShariqShamimMD @harvardmed @EmoryUniversity
RT @uppsalamats: @EgorPutilov Behövdes inte så många minuter innan jag hittade denna i Journal of Thrombosis and Haemostasis: “Anticoagulan…
@EgorPutilov Antar att denna fungerar https://t.co/VISaEfU2GK
@EgorPutilov Behövdes inte så många minuter innan jag hittade denna i Journal of Thrombosis and Haemostasis: “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”, från mars 2020.
RT @enezif1133: دراسة من #ووهان_الصينية تقول أن فحص معاملات التخثر لدى مرضى #Covid_19 تحمل أهمية كبرى في توقع مصير المريض . العلاج بحقن سي…
@robymes @TeoCap @cris_cersei https://t.co/lw8ycz84r4
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/xz4yAmG5ue
RT @ociredeF_MD: Primeras evidencias de lo que se venia observando. Anticoagulant treatment is associated with decreased mortality in seve…
@MountainWarbler @sunmaster14 @MartinOKnight @inQistveStephen @niro60487270 @mad_duc https://t.co/haqzfQ1388
@MountainWarbler @sunmaster14 @MartinOKnight @inQistveStephen @niro60487270 @mad_duc https://t.co/haqzfQ1388
RT @MEXI_COVID: Tromboprofiláxis con enoxaparina 40-60 mg/día en pacientes hospitalizados con: •Dímero-D > 3.0 μg/mL. •SIC score ≥4 Logr…
@BolsonaroSP @bernardopkuster @JornalBSM Isso aqui está dando resultado: https://t.co/C5UgbLQSfF
@BolsonaroSP @bernardopkuster @JornalBSM Isso aqui tem dado resultado: https://t.co/C5UgbLQSfF
@z1y2x3 Also: https://t.co/W7erF97yzl
29/
@carolini @rolodebolo Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://t.co/JhAd9Op8m8
RT @2minmed: #VisualAbstract: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients wi…
RT @rincondesisifo: (2 minute medicine) Tto anticoagulante y mortalidad en pac con #COVID19 y coagulopatías https://t.co/ODAmlPf0oq Infogra…
(2 minute medicine) Tto anticoagulante y mortalidad en pac con #COVID19 y coagulopatías https://t.co/ODAmlPf0oq Infografía de Est Observ https://t.co/eHMNDVHbgw
#VisualAbstract: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/0QkXDHkwKS #StudyGraphics #disseminatedintravascularcoagulationDIC https://t.co/ci5kDbiqBF
RT @ItalObserver: @Yi_Benevolence I cinesi, probabilmente più seri di noi ma anche colpiti prima, invece di fare dirette Facebook complotti…
@Yi_Benevolence I cinesi, probabilmente più seri di noi ma anche colpiti prima, invece di fare dirette Facebook complottiste hanno fatto studi veri e pubblicato dati, che tra l’altro dimostrano che anticoagulanti possono aiutare alcuni pazienti ma danneggiare altri: https://t.co/AIeu5iiscC
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy - Tang - 2020 - Journal of Thrombosis and Haemostasis https://t.co/YLpAfb7NPz https://t.co/N6TTdw6Jqj
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
RT @Bob_Wachter: 18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at a…
18/ Two observational studies (one from China https://t.co/gENQEwCIEN, other from NYC https://t.co/6tEh3J8Cpg) looked at anticoagulation, an area of intense interest given propensity of Covid patients to clot. Both studies showed better outcomes for some patients w/ severe Covid.
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/hXQQxCUNYQ
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/YENBoPYUNN
The recent news on #anticoagulant therapy for #COVID19 #SARSCoV2 #coronavirus is showing promise to extend lives but it needs to be given only in the right circumstance. If there is no problem with clotting, you may make the situation worse. https://t.co/MWQJknWPi4
Retrospective study! https://t.co/7fYLyKbbB6
RT @MEXI_COVID: Tromboprofiláxis con enoxaparina 40-60 mg/día en pacientes hospitalizados con: •Dímero-D > 3.0 μg/mL. •SIC score ≥4 Logr…
https://t.co/gHfCUeshHZ
Tromboprofiláxis con enoxaparina 40-60 mg/día en pacientes hospitalizados con: •Dímero-D > 3.0 μg/mL. •SIC score ≥4 Logró una reducción de mortalidad de aprox. 20% a los 28 días, comparado con los que no recibieron enoxaparina. #COVID19 Referencias: https://t.co/A9o1UeRpU6 https://t.co/gbzbjdE1Wf
Em outro artigo mais recente do mesmo grupo, publicado no dia 27 de março, o uso de terapia anticoagulante com heparina demonstrou diminuir a mortalidade destes pacientes em cerca de 20%. https://t.co/SkLO1PJFoH
RT @sanchak74: @BillyBostickson Heparin... https://t.co/uZ0CWVAARo
RT @KU_KPSS: Anticoagulants and COVID19 Do they have a role? https://t.co/Q4BEpaD3vz https://t.co/XFKrvQBFDU
Anticoagulants and COVID19 Do they have a role? https://t.co/Q4BEpaD3vz https://t.co/XFKrvQBFDU
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/6c9sqkKxx9
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/4BEvSx6TfO
RT @JTHjournal: New accepted #COVID19 article shows #anticoagulant treatment is associated with decreased mortality in severe COVID-19 pati…
RT @EmergPharm: Lots of discussion about management of COVID associated coagulopathy. Some great resources below: https://t.co/OKvXgPENqP…
Lots of discussion about management of COVID associated coagulopathy. Some great resources below: https://t.co/OKvXgPENqP https://t.co/tl8jtSazka https://t.co/ChtT8Csa4c https://t.co/qQIyDd16Z3 https://t.co/gC3pUGaLxh @EmedUg @Seed_Global @UVMEmergencyMed #ECSU #staysafeUg
@BahjetWamda It's true but I think not necessarily in the lungs https://t.co/4ET93JSa9I
@_RL_W @nanogenomic @abledoc Have you read this research? https://t.co/W7erF97yzl
RT @leticiakawano: 1/ #medtwitter dealing with #covid19 patients Any thoughts on anticoagulation to these patients? https://t.co/tjDtmPZspR…
@plums_the @AntonelloAng Ma che ne sai tu? Ci lavori in ospedale a Pavia o hai sentito colleghi in vena di show? Quali sono i dati che dimostrano che EBPM o idrossiclorochina “svuotano” le rianimazioni? Almeno i cinesi pubblicano su riviste scientifiche non fanno comizi sui social https://t.co/2qxjMPli9l
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/ccqNRiHDi5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coa… https://t.co/X5uYxdeW5d
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Some papers covering the topic; doi: 10.1111/bjh.16725. Changes in coag parameters in severe COVID-19 doi: 10.1111/JTH.14817. Anticoagulants in patients with severe COVID-19 doi: 10.1111/jth.14830. VTE in patients with severe COVID-19 pneumonia
@thiamparo @savionf @dadourado Tem esse estudo https://t.co/ZAKLTIfUNb
RT @Predimed_techno: Le site https://t.co/ui93iqbVUc réalise une veille et analyse de la littérature #médicale et #scientifique dédiée au #…
Le site https://t.co/ui93iqbVUc réalise une veille et analyse de la littérature #médicale et #scientifique dédiée au #Coronavirus Analyse du Dr HERB Agathe Télécharger l'article et l'analyse complète ici ➡️ https://t.co/l0lfJMmMG7 @CHRUStrasbourg @JTHjournal #COVID19 https://t.co/Eo2gonGbNJ
RT @litcovid_nyu: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopa…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @FaheemMalam: There’s a growing belief that in some Covid patients we see the formation of thrombi in the vasculature of the lungs: Ant…
Sharing an article with interesting findings: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/jOucQ5veiD
Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy - PubMed https://t.co/XSaWDei96u
@caiovsgg Ask them to cite this paper for support... https://t.co/uZ0CWVAARo
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coa… https://t.co/vJSVfDEKa0
https://t.co/bgCadnMKeO. Interesante!!
RT @litcovid_nyu: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopa…
RT @litcovid_nyu: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopa…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy High Yield Points * Patients with severe #COVID19 had reduced 28-day mortality with heparin use Review by @noahrosenberg1 doi:10.1111/jth.14817 https://t.co/EQ9vw86tUB
RT @slovborg: @DrEricDing Not really new... https://t.co/lL8BLMoArD
@hopeseekr Not really new... https://t.co/lL8BLMoArD
@DrEricDing Not really new... https://t.co/lL8BLMoArD
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronaviru…
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronaviru…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
El tratamiento anticoagulante se asocia con una disminución de la mortalidad en pacientes con enfermedad grave por coronavirus 2019 con coagulopatía. Link: https://t.co/095e6H6BK1 https://t.co/c96mDgtoQo
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy - Tang - - Journal of Thrombosis and Haemostasis - Wiley Online Library https://t.co/yw0uc0vrqd
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
@G_House__MD @DrEricDing Have you read about threshold heparin dosing to decrease excessive clotting events in severe COVID-19 patients? https://t.co/W7erF97yzl
@miguelm_barrios lo que me parece interesante es la falta de un estudio en proceso, claro que es sabido que en CID vas a usar anticoagulantes pero no hay estudio especifico para covid 19 expandi todos creyeron las autopsias? https://t.co/gFTxmrM9lS https://t.co/xOpgw9GDRi https://t.co/N9E3r4YJQg
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @ZLevyMD: It's all about the clotting! Significant mortality reduction (52% vs 32%) using dimer cutoff alone in severe #COVID19. Yes,…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @ZLevyMD: It's all about the clotting! Significant mortality reduction (52% vs 32%) using dimer cutoff alone in severe #COVID19. Yes,…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
It's all about the clotting! Significant mortality reduction (52% vs 32%) using dimer cutoff alone in severe #COVID19. Yes, this study stinks for several reasons. 60mg/kg LMWH is prophy, not treatment. But is there a signal somewhere in that noise? https://t.co/Ojz9aYbD4j
@farmagemma He recopilado varios papers bastante recientes y con el peer review pendiente que apuntan a coagulopatías en covid-19 como apunta algún especialista: ahí van https://t.co/xcicDumjhX https://t.co/NLMoLdgOpD https://t.co/NAEOhWRy3a https://t.co/VNNK8bXu4P
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/CDLO3ZEF1K
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy - Tang - - Journal of Thrombosis and Haemostasis - Wiley Online Library https://t.co/LCfvXV5m7D
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronaviru…
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronaviru…
RT @mtmdphd: @Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant therapy mainly with LMWH appears to be associated with better prognos…
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
RT @chuletadeosler: Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYv…
Tang et al: HBPM en covid19 reduce mortalidad? Cómo se produce coagulación intravascular? Completo: https://t.co/ZtzlYvSxWT Ref: https://t.co/myx7pxuzg9 #coronavirus #COVIDー19 #sarscov2 #foam #foamed #foamems #meded #foamcc #covid19primaria #mfyc #enarm #mir https://t.co/hxikyubylo
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
RT @IscoTypes: @orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
@ParaMicroBio @colinrivas @MiguelngelMorc2 @LuisPolonio6201 @alaska_doctor https://t.co/7ta1E7TbJX
@orbangabea @floresconencant @vite49 @rejopelines @alaska_doctor https://t.co/7ta1E7TbJX
@carpraba @julianig @alaska_doctor Si los hay. Aquí les dejo uno, claro que debe haber una buena valoración para ver si se es apto para la administración de anticoagulantes (en este caso heparina de bajo peso molecular). https://t.co/7ta1E7TbJX
RT @BibliotecaHUCA: PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coro…
@Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant therapy mainly with LMWH appears to be associated with better prognosis in severe COVID‐19 patients meeting SIC criteria or with markedly elevated D‐dimer. [Mar 27, 2020] Tang et al. @JTHjournal https://t.co/yiuv1YYb5g #VTE #2019nCoV #COVID19
@Dr_al_assadi @GermHunterMD @DeNovo_Fatima Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy [Mar 27, 2020] Tang et al. @JTHjournal https://t.co/yiuv1YYb5g #VTE #2019nCoV #COVID19
RT @BibliotecaHUCA: PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coro…
RT @BibliotecaHUCA: PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coro…
RT @BibliotecaHUCA: PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coro…
RT @BibliotecaHUCA: PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coro…
PubMed- https://t.co/Qur1I6YTsT Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy". @HUCA_Asturias #publiHUCA @rubencotoh #InternalMedicine
RT @alejandrosuazov: El coronavirus aparentemente no causa neumonía, sino trombosis de acuerdo a últimos estudios. Es la forma como se ha c…
@AngrierWHStaff Also https://t.co/zHF61Vlbwr
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @mtmdphd: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy […
https://t.co/yzzqZbhLD7
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @ErinSandersNP: 10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Co…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
@DrEricDing Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/GOwR8Qqqo6
@ethanjweiss https://t.co/TCVsCQkRIP In Itali heparin is being used. And soon the shortage of heparin will come to light too.
"Senza fondamento". https://t.co/V0aKjYU8pH https://t.co/FTgqoVrRtB
RT @OjinoSosa: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Discusión y conclusiones de los resultados. https://t.co/Omz8EcJGwr vía @SyM_Intensiva
Un nuevo giro en el tratamiento en pacientes covid-19, una nueva esperanza. https://t.co/RUdQllrsSr
https://t.co/RUdQllrsSr
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy - PubMed https://t.co/FXzqipqw9t
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @anita15618428: @Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni mo…
Sull'uso di #eparina nel #Covid_19 : "Anticoagulant treatment is associated with decreased mortality in severe #coronavirus disease 2019 patients with coagulopathy." #COVID19italia #coronavirusitalIa https://t.co/BTpwKkuhIB
RT @anita15618428: @Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni mo…
@Nonha_stata https://t.co/EWaJd5lDGh è associata ad un miglioramento. L’efficacia mi pare troppo ottimista...ad ogni modo questo è lo studio con i risultati ❤️di certo non é una bufala
RT @khalid_eljaaly2: Based on this study, would you recommend anticoagulants during #COVID19 therapy? How? https://t.co/Fl8dxesuR3
https://t.co/NC0mId6AdW
RT @CaptainKidney79: @SaadTheodore @abtahi_parvaneh @VijayanMD @wasse_m @NephRodby @mrssaradavid @ASDINNews @dialysisaccess1 @criticalbeans…
@KiraNewmanMDPhD I wonder if heparin is being used in current treatments of patients in Seattle. https://t.co/TCVsCQkRIP
@stanzaselvaggia In realtà il caso è un po' più complesso e naturalmente le osservazioni primarie vengono dalla Cina più che da Pavia. https://t.co/JalcJG4v15
RT @ricardo_bedon: Great article: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patient…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
@RobertoBurioni @NEJM @TheLancet Ormai è evidente che il problema vero non è respitario ma vascolare. Le autopise hanno mostrato frequenti decessi causa tromboembolia diffusa. Farmaci quali cortisone eparina e tocilizumab sono efficaci! https://t.co/cWZPCwW46F
Great article: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://t.co/RFiPmuZuun #ReadByQxMD
RT @ricardo_bedon: Great article: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patient…
https://t.co/xCHDpMoKX4
Great article: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://t.co/pmlQ792Pqq #ReadByQxMD
This is relevant. #COVID19 #coronavirus Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://t.co/gSfVSGmpOd
RT @AtrashShebli: Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coa… http…
Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coa… https://t.co/mycbbcG2Ss
RT @ErinSandersNP: 10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Co…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy - PubMed https://t.co/H4uZcpFc1G
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
RT @AmbrizMau: Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con CO…
Anticoagulación (HEPARINA DE BAJO PESO MOLECULAR) parece asociarse con menor mortalidad a 28 días en pacientes graves con COVID-19 que presentan coagulopatía por sepsis (40% vs 64.2% [p=0.029]) o dímero D >6 veces ULN (32.8% vs 52.4% [p=0.017]). DOI: https://t.co/LhfvOpQ22x https://t.co/eAFDvFKdIY
RT @Abraham_RMI: @doctormacias Referencia
COVID 19 - coagulation disorders / thrombosis, DIC & thrombotic complications seem to emerge as an Imp issue in infected patients .. important role for anticoagulation and #hematology https://t.co/UBsnpZEFT6
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
Possiamo sperare? @RobertoBurioni https://t.co/QrYtnqvu3o
RT @khalid_eljaaly2: Based on this study, would you recommend anticoagulants during #COVID19 therapy? How? https://t.co/Fl8dxesuR3
RT @ErinSandersNP: 10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Co…
RT @Abraham_RMI: @doctormacias Referencia
RT @enezif1133: دراسة من #ووهان_الصينية تقول أن فحص معاملات التخثر لدى مرضى #Covid_19 تحمل أهمية كبرى في توقع مصير المريض . العلاج بحقن سي…
RT @Abraham_RMI: @doctormacias Referencia
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://t.co/1PiAVeLfJu
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
@AsherElad @SABOURETCardio @gabrielsteg @EM_RESUS @JEscaned @CherylZogg @frubulotta @sbrugaletta @PhilGenereuxMD @ESC_Journals @DFCapodanno @PCRonline @Dr_Iakobishvili @BeigelRoy @Israel_Mazin @maor_elad Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy for patients with a high ddimer or sic sccore- Tang - - Journal of Thrombosis and Haemostasis - Wiley Online Library https://t.co/NHc8WDpPRH
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
RT @SeanM_Wu: @iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmur…
@iamritu @DrMarthaGulati @ErinMichos @purviparwani @JGrapsa @mmamas1973 @fischman_david @arghavan_salles @rajdoc2005 @venkmurthy @willsuh76 V interesting webinar from Int'l Soc of Haemostasis Thrombosis - Retrospective analysis of 449 severe #COVID19 pts from China shows 40% mortality in pts tx w heparin vs 64% tx without. (Tang, N. et al J Thrombosis & Haemostasis. https://t.co/ThU72ygX2q) @ethanjweiss @willsuh76
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
RT @EvidenciaTer: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopa…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/uG2suErzAt
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy #AyudaBiblioteca @ssantri https://t.co/QvruSOw4my
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/f8DMmBPk74
10/ Anticoagulant Treatment Is Associated With Decreased Mortality in Severe Coronavirus Disease 2019 Patients With Coagulopathy (China) https://t.co/JxKabFDaK2
There’s a growing belief that in some Covid patients we see the formation of thrombi in the vasculature of the lungs: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/RYcgFzAFro
RT @santamariaparo: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulo…
Publicación Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients w... https://t.co/OuVULNzsBH
RT @avkwong: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy…
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy https://t.co/5tSUpH1uqa #covid19 https://t.co/GsNvak4bYT
RT @mtmdphd: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy […
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/32220112
Heparin associated with decreased mortality in subgroup of #COVID19 patients: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jth.14817 Interesting discussion of potential mechanisms of benefit from heparin here: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jth.14821